Format

Send to

Choose Destination
Pharmacol Res. 2019 Mar 4. pii: S1043-6618(18)31953-4. doi: 10.1016/j.phrs.2019.02.030. [Epub ahead of print]

Pharmacological targeting of age-related changes in skeletal muscle tissue.

Author information

1
Biozentrum, University of Basel, Klingelbergstrasse 50/70, CH-4056, Basel, Switzerland.
2
Biozentrum, University of Basel, Klingelbergstrasse 50/70, CH-4056, Basel, Switzerland. Electronic address: christoph.handschin@unibas.ch.

Abstract

Sarcopenia, the age-related loss of skeletal muscle mass and function, increases the risk of developing chronic diseases in older individuals and is a strong predictor of disability and death. Because of the ongoing demographic transition, age-related muscle weakness is responsible for an alarming and increasing contribution to health care costs in Western countries. Exercise-based interventions are most successful in preventing the decline in skeletal muscle mass and in preserving or ameliorating functional capacities with increasing age. However, other treatment options are still scarce. In this review, we explore currently applied nutritional and pharmacological approaches to mitigate age-related muscle wasting, and discuss potential future therapeutic avenues.

KEYWORDS:

Aging; Exercise; Nutrition; Sarcopenia; Skeletal muscle; mTORC1

PMID:
30844535
DOI:
10.1016/j.phrs.2019.02.030

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center